HomeNewsBusinessReal EstateSBICap stressed fund receives 100 fresh applications; number likely to double

SBICap stressed fund receives 100 fresh applications; number likely to double

The fund has received applications from both Tier 1 and Tier 2 cities such as Jaipur, Karnal, Mohali and Panchkula, Nagpur and Nasik. Smaller developers facing challenges to comply with the initial due diligence process

June 17, 2020 / 11:31 IST
Story continues below Advertisement

SBICAP Ventures, the manager for the government's Rs 25,000-crore stressed-asset fund, has received more than 100 new applications from real estate developers during the COVID-19 crisis after it decided to cut the internal rate of return (IRR). The number is expected to double in the near future, sources told Moneycontrol.

The fund has received applications from Tier 1 cities and also from Tier 2 towns such as Jaipur, Karnal, Mohali and Panchkula, Nagpur and Nasik. Developers have sought an investment ranging from Rs 10 crore to Rs 400 crore for the stalled projects, they said.

Story continues below Advertisement

They have received more than 100 proposals over the last one month but are facing challenges on account of the coronavirus pandemic, sources said.

While Tier 1 developers have found it easier to send the information required even from remote locations as they have access to digitized documents, smaller developers are finding it difficult to execute the initial due diligence process as borders may be sealed or physical documents may be kept in a different location, sources said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show